French CAR-T biotech Mnemo Therapeutics shutters US operations
A Sofinnova-backed CAR-T maker has shut down its New York and Princeton, NJ sites and will continue operating out of its Paris hub.
Mnemo Therapeutics turned the lights off at its US operations effective immediately on Feb. 23, according to employees’ posts on LinkedIn and confirmation from co-founder and operating chief Alain Maiore.
“When Sebastian [Amigorena] and I started Mnemo Tx, we were looking to build a company where the human value of ‘standing shoulder to shoulder’ in difficult time would typify the DNA of our teams across the ocean,” Maiore wrote on LinkedIn in recent days. “The decision we had to make about shutting down our US operations, to move back our CT effort to Europe, next to our target discovery platform was a very difficult one.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.